- Home
- DELL vs BMY Comparison
DELL vs BMY Comparison
Compare DELL & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DELL | BMY |
|---|---|---|
| Founded | 1984 | 1887 |
| Country | United States | United States |
| Employees | N/A | 32500 |
| Industry | Computer Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 140.5B | 115.3B |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | DELL | BMY |
|---|---|---|
| Price | $295.42 | $59.62 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 15 |
| Target Price | ★ $181.63 | $61.73 |
| AVG Volume (30 Days) | 4.9M | ★ 8.8M |
| Earning Date | 05-28-2026 | 04-30-2026 |
| Dividend Yield | 1.23% | ★ 4.38% |
| EPS Growth | ★ 36.05 | N/A |
| EPS | ★ 8.68 | N/A |
| Revenue | ★ $113,538,000,000.00 | N/A |
| Revenue This Year | $26.19 | N/A |
| Revenue Next Year | $8.60 | N/A |
| P/E Ratio | $29.21 | ★ $17.26 |
| Revenue Growth | ★ 18.80 | N/A |
| 52 Week Low | $106.38 | $42.52 |
| 52 Week High | $263.99 | $62.89 |
Technical Indicators
Market Signals| Indicator | DELL | BMY |
|---|---|---|
| Relative Strength Index (RSI) | 76.67 | 60.11 |
| Support Level | $117.64 | $59.23 |
| Resistance Level | N/A | $60.63 |
| Average True Range (ATR) | 15.40 | 1.16 |
| MACD | 2.19 | 0.39 |
| Stochastic Oscillator | 96.68 | 86.89 |
Price Performance
Historical ComparisonAbout DELL Dell Technologies Inc.
Dell Technologies is a broad information technology vendor, primarily supplying hardware to enterprises. It focuses on premium and commercial personal computers, as well as enterprise on-premises data center hardware. It holds top-three shares in its core markets of personal computers, peripheral displays, mainstream servers, and external storage. Dell has a robust ecosystem of component and assembly partners and also relies heavily on channel partners to fulfill its sales.
About BMY Bristol-Myers Squibb Company
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.